Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
5 May, 26
WCO-IOF-ESCEO 2026
Key sessions on diabetes and bone health in osteoporotic patients presented at the 26th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Prague, Czech Republic.
5 May, 26
WCO-IOF-ESCEO 2026
Key sessions focusing on osteoporosis therapy presented at the 26th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Prague, Czech Republic.
21 May, 26
Endocr Pract.
- Amongst 406 hyperglycemic crisis patients [303 diabetic ketoacidosis (DKA), 103 hyperosmolar hyperglycemic state (HHS)], 14.8% had acute pancreatitis (AP), more frequent in DKA (17.5%) vs HHS (6.8%)
- Higher BMI, abdominal pain, shock, high γ-GTP, & hypertriglyceridemia predicted AP
- Alcohol use, T2DM, abdominal pain, shock, & γ-GTP predicted AP in DKA
- AP increased ICU admission but not hospital stay or mortality.
18 May, 26
Diabetic Med.
- As per the meta-analysis of 22 studies (13074868 subjects; 2644443 with T2DM), T2DM raised fracture risk by 25%
- Risk was higher for lower limb fractures (HR 1.43), upper limb (HR 1.29), osteoporotic/fragility (HR 1.14), & unspecified fractures (HR 1.25)
- The link was robust in women & in those with longer T2DM duration
- Targeted fracture prevention strategies & focused risk assessment is critical in T2DM patients.
15 May, 26
Clin. Microbiol. Inf...
- Short course (2–5 d) antibiotics similar to ≥7 d for relapse and reinfection.
- No significant difference in clinical or bacteriological cure rates.
- Adverse events comparable between short and long courses.
- Shorter therapy appears effective/safe; more data needed in infants/recurrent UTI.
15 May, 26
BMJ Diabetes Open Re...
- Amongst 1,208 patients with T2DM & hypertension (mean age 58.3; 60.1% male), 42.5% had fibrosis-4 (FIB-4) index > 1.3
- Elevated FIB-4 was independently associated with KDIGO 3–4 (high/very high risk) (OR 1.57, p=0.008) & CKD (OR 1.51, p=0.004)
- Even within KDIGO low-risk groups, high FIB-4 correlated with vascular comorbidities (p<0.01)
- FIB-4 may complement KDIGO for early CKD risk stratification.
Featured

22 May, 26

13 May, 26

13 May, 26
















